PT  - JOURNAL ARTICLE
AU  - Matthew F. Sharrock
AU  - W. Andrew Mould
AU  - Hasan Ali
AU  - Meghan Hildreth
AU  - Issam A. Awad
AU  - Daniel F. Hanley
AU  - John Muschelli
TI  - 3D Deep Neural Network Segmentation of Intracerebral Hemorrhage: Development and Validation for Clinical Trials
AID  - 10.1101/2020.03.05.20031823
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.05.20031823
4099  - http://medrxiv.org/content/early/2020/03/08/2020.03.05.20031823.short
4100  - http://medrxiv.org/content/early/2020/03/08/2020.03.05.20031823.full
AB  - Intracranial hemorrhage (ICH) occurs when a blood vessel ruptures in the brain. This leads to significant morbidity and mortality, the likelihood of which is predicated on the size of the bleeding event. X-ray computed tomography (CT) scans allow clinicians and researchers to qualitatively and quantitatively diagnose hemorrhagic stroke, guide interventions and determine inclusion criteria of patients in clinical trials. There is no currently available open source, validated tool to quickly segment hemorrhage. Using an automated pipeline and 2D and 3D deep neural networks, we show that we can quickly and accurately estimate ICH volume with high agreement with time-consuming manual segmentation. The training and validation datasets include significant heterogeneity in terms of pathology, such as the presence of intraventricular (IVH) or subdural hemorrhages (SDH) as well as variable image acquisition parameters. We show that deep neural networks trained with an appropriate anatomic context in the network receptive field, can effectively perform ICH segmentation, but those without enough context will overestimate hemorrhage along the skull and around calcifications in the ventricular system. We trained with all data from a multi-center phase II study (n = 112) achieving a best mean and median Dice coefficient of 0.914 and 0.919, a volume correlation of 0.979 and an average volume difference of 1.7ml and root mean squared error of 4.7ml in 500 out-of-sample scans from the corresponding multi-center phase III study. 3D networks with appropriate anatomic context outperformed both 2D and random forest models. Our results suggest that deep neural network models, when carefully developed can be incorporated into the workflow of an ICH clinical trial series to quickly and accurately segment ICH, estimate total hemorrhage volume and minimize segmentation failures. The model, weights and scripts for deployment are located at https://github.com/msharrock/deepbleed. This is the first publicly available neural network model for segmentation of ICH, the only model evaluated with the presence of both IVH and SDH and the only model validated in the workflow of a series of clinical trials.Competing Interest StatementDFH reports personal fees from BrainScope, Neurotrope, Op2Lysis, Portola Pharmaceuticals, and medico-legal consulting, outside the submitted work. The other authors have no conflicts of interest to report.Funding StatementThe MISTIE trials were supported by grants awarded to DFH by the National Institutes of Health’s National Institute of Neurological Disorders and Stroke [MISTIE II: R01NS046309; MISTIE III: U01NS080824], with alteplase donated by Genentech for U.S. and Canadian sites. DFH is further supported by NIH grant U24TR001609. The funding sources had no involvement in this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublicly available software packages for immediate download for 3D Deep Neural Network Segmentation and Preprocessing Python are hosted at https://github.com/msharrock/deepbleed and for the random forest model and preprocessing in R at https://github.com/muschellij2/ichseg. The data archives for the MISTIE and MISTIE III clinical trials are available through submission to the National Institute of Neurological Disorders and Stroke Clinical Research Liaison https://www.ninds.nih.gov/Current-Research/Research-Funded-NINDS/ClinicalResearch/Archived-Clinical-Research-Datasets. https://github.com/msharrock/deepbleed https://github.com/muschellij2/ichseg